SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway
about
Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative StressIdentifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic reviewRoles of the canonical myomiRs miR-1, -133 and -206 in cell development and diseaseMicroRNAs: a new piece in the paediatric cardiovascular disease puzzleMicroRNAs in heart failure: Small molecules with major impactForkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathyDistinctive profile of IsomiR expression and novel microRNAs in rat heart left ventricle.Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetesRole of microRNA-1 in human cancer and its therapeutic potentials.High-salt intake suppressed microRNA-133a expression in Dahl SS rat myocardiumLaser-targeted ablation of the zebrafish embryonic ventricle: a novel model of cardiac injury and repair.Application of time-resolved autofluorescence to label-free in vivo optical mapping of changes in tissue matrix and metabolism associated with myocardial infarction and heart failure.Targeting cardiomyocyte Ca2+ homeostasis in heart failure.Exercise training restores the cardiac microRNA-1 and -214 levels regulating Ca2+ handling after myocardial infarction.Diabetic cardiomyopathy and metabolic remodeling of the heart.Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling.The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy.Alterations in ryanodine receptors and related proteins in heart failureKetanserin improves cardiac performance after myocardial infarction in spontaneously hypertensive rats partially through restoration of baroreflex function.MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy.miRNA-1: functional roles and dysregulation in heart disease.Noncoding RNAs and myocardial fibrosis.The regulation of sarco(endo)plasmic reticulum calcium-ATPases (SERCA).Intercellular communication lessons in heart failure.A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling.microRNAs and Cardiovascular Remodeling.The regulatory function of microRNA-1 in arrhythmias.MicroRNA-1 overexpression blunts cardiomyocyte hypertrophy elicited by thyroid hormone.Does proteasome regulate the level of microRNA-1 in cardiomyocytes? Application to anoxia-reoxygenation.Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats.Emerging molecular therapies targeting myocardial infarction-related arrhythmias.A Circular RNA Binds To and Activates AKT Phosphorylation and Nuclear Localization Reducing Apoptosis and Enhancing Cardiac Repair.MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential.Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy.Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury.The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations.Oleanolic acid alleviated pressure overload-induced cardiac remodeling.
P2860
Q26744498-46ECE853-E589-46D1-9173-F787089F5BF3Q26746063-ED943001-B38B-4559-8B7D-A48B74AC8459Q26795757-4599F659-B9A1-48F1-A902-F29A12149BD0Q26822990-9FCEF7CA-2FD4-4A5C-BF44-1971A9585DEBQ27024714-68851B20-CDA3-4CF9-9574-9B35F30132DAQ28080067-1160DA07-5CB1-4046-874E-7EA4D5B16A05Q31120462-BC08438E-9C1C-4A01-BBE5-BA698F52D9CFQ33671476-F8B03BE9-7816-4A0D-BEFF-B9D6D6C45C7DQ33737275-7C24B6C0-E5A2-456A-AF72-395663D47E27Q33907885-A78E9D28-81F2-4CC0-A22C-9761694D52F4Q34841601-52967F7D-8B18-4CA1-B212-5B02EB531BADQ35162103-49767119-CC5A-4744-B18C-9EAC392BC095Q35763705-846812EA-3B02-4BD8-B9D8-B13EAC88521BQ35863394-51213E11-D266-441C-AB9C-7F0EBCD020E9Q36672871-1111D4CF-917C-4363-B3AA-AFCF1B6F1F7CQ36824801-206C0822-2FD6-41A3-8905-DBCA011B274EQ36855897-C247DC7F-7059-468A-9DED-3C0783975BE9Q37074084-F3187BB7-04F3-41D2-8892-6BEAE2DDA626Q37239340-36BDD4AB-8F22-446C-8347-ADF945D5F3E5Q37728441-85A5C8DC-8849-4002-A20E-82A073AA347FQ38161836-AE0A6105-1EDC-4618-918A-1F55DA78ED5EQ38182139-EEE6D510-0EBF-4561-8EDC-AFEA9C6EE6E4Q38245253-ED901CEC-8488-45FD-A344-799FF8661F43Q38247018-C2058AAC-DDF3-4609-9317-0AB0BEE1E013Q38366647-31D440D1-CF42-40AD-8EDE-CD198B3F3E1DQ38591546-934A4258-84BD-409A-B29C-EFA648BDC540Q38656290-2435A8CC-6999-419D-B477-E7FB9EE0B16BQ38668255-2CD98D88-25B3-42DE-BAD0-6F49E52215D8Q38670411-FA087E6C-9F3D-40A9-BF31-493D63F1AF01Q39034552-266CC10A-17C4-4E1F-85B3-C4FEEDA7A361Q41338072-6CC61516-9A63-4E9B-A3D4-A61150B5B266Q43375823-736524EC-1204-4E42-BA9B-68341F77E8DFQ45866944-9E4F1CB2-E2CE-4777-93A7-2CA09AEC42FEQ47150021-F64EDB82-1090-4CA0-AC71-40806FA448BFQ47644374-A3C848EB-5F9A-45A0-A108-7DF4EE67CF62Q50062611-6BC26683-C8C2-435B-B598-9043810C3092Q50089772-4CC85F49-CE93-4E62-BA94-9D697B0D96C3Q50198230-A8E6D1DD-1D76-479D-9A2F-BD67C2FCFA57Q50611647-F6E88DDA-C6EC-4FCB-8DE9-9A3456E5AC2EQ53405909-520273FC-7A06-4BA7-92C4-CBDFA5919C4D
P2860
SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway
description
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2012
@ast
im Mai 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2012/05/01)
@nl
наукова стаття, опублікована в травні 2012
@uk
مقالة علمية (نشرت في مايو 2012)
@ar
name
SERCA2a gene therapy restores ...... n Akt/FoxO3A-dependent pathway
@ast
SERCA2a gene therapy restores ...... n Akt/FoxO3A-dependent pathway
@en
type
label
SERCA2a gene therapy restores ...... n Akt/FoxO3A-dependent pathway
@ast
SERCA2a gene therapy restores ...... n Akt/FoxO3A-dependent pathway
@en
prefLabel
SERCA2a gene therapy restores ...... n Akt/FoxO3A-dependent pathway
@ast
SERCA2a gene therapy restores ...... n Akt/FoxO3A-dependent pathway
@en
P2093
P2860
P921
P3181
P356
P1476
SERCA2a gene therapy restores ...... n Akt/FoxO3A-dependent pathway
@en
P2093
Aanchal Pahuja
Adam M Mills
Alexander R Lyon
Cornelia Geers-Knörr
Ingo Volkmann
Julia Bretthauer
Kenneth T Macleod
Regalla Kumarswamy
Roger J Hajjar
Theresia Kraft
P2860
P304
P3181
P356
10.1093/EURHEARTJ/EHS043
P577
2012-02-23T00:00:00Z